NASDAQ: TDAC
Translational Development Acquisition Corp Stock

$10.11+0.01 (+0.1%)
Updated Apr 23, 2025
TDAC Price
$10.11
Fair Value Price
N/A
Market Cap
$221.48M
52 Week Low
$10.00
52 Week High
$10.20
P/E
-505.5x
P/B
-39.57x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$71.01k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.12
Operating Cash Flow
-$851k
Beta
-0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

TDAC Overview

Trident Acquisitions Corp. is a shell company. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company focuses on identifying a business to a particular industry or geographic region of the world. The Company is focused on seeking business combination with oil and gas or other natural resources companies in Eastern Europe. The Company is not engaged in any business operations.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine TDAC's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Shell Company

Industry Rating
F
TDAC
Ranked
#14 of 18

Top Ranked Stocks in Industry

View Top Shell Company Stocks

Be the first to know about important TDAC news, forecast changes, insider trades & much more!

TDAC News

Overview

Due Diligence Score

Industry Average (11)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TDAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TDAC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TDAC is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
TDAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more TDAC due diligence checks available for Premium users.

Valuation

TDAC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-505.5x
Industry
-26.39x
Market
26.95x

TDAC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-39.57x
Industry
-52.68x

TDAC's financial health

Profit margin

Revenue
$0.0
Net Income
-$8.0k
Profit Margin
0%
TDAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$175.0M
Liabilities
$6.2M
Debt to equity
-1.12
TDAC's short-term assets ($650.23k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TDAC's long-term liabilities ($6.04M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TDAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TDAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$811.0k
Investing
$0.0
Financing
$175.3M
TDAC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TDAC vs Shell Company Stocks

TickerZen RatingMarket Cap1d %P/EP/B
TDACC$221.48M+0.10%-505.50x-39.57x
MACI$222.27M0.00%39.54x-40.22x
DYNX$220.45M0.00%-498.00x-29.01x
SVCC$216.37M+0.20%-333.67x-4,257.32x
CEP$211.20M+55.37%68.75x-136.26x

Translational Development Acquisition Stock FAQ

What is Translational Development Acquisition's quote symbol?

(NASDAQ: TDAC) Translational Development Acquisition trades on the NASDAQ under the ticker symbol TDAC. Translational Development Acquisition stock quotes can also be displayed as NASDAQ: TDAC.

If you're new to stock investing, here's how to buy Translational Development Acquisition stock.

What is the 52 week high and low for Translational Development Acquisition (NASDAQ: TDAC)?

(NASDAQ: TDAC) Translational Development Acquisition's 52-week high was $10.20, and its 52-week low was $10.00. It is currently -0.88% from its 52-week high and 1.1% from its 52-week low.

How much is Translational Development Acquisition's stock price per share?

(NASDAQ: TDAC) Translational Development Acquisition stock price per share is $10.11 today (as of Apr 23, 2025).

What is Translational Development Acquisition's Market Cap?

(NASDAQ: TDAC) Translational Development Acquisition's market cap is $221.48M, as of Apr 24, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Translational Development Acquisition's market cap is calculated by multiplying TDAC's current stock price of $10.11 by TDAC's total outstanding shares of 21,907,500.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.